Why All the Fuss about Oxidative Phosphorylation (OXPHOS)?


Journal

Journal of medicinal chemistry
ISSN: 1520-4804
Titre abrégé: J Med Chem
Pays: United States
ID NLM: 9716531

Informations de publication

Date de publication:
10 12 2020
Historique:
pubmed: 27 10 2020
medline: 2 2 2021
entrez: 26 10 2020
Statut: ppublish

Résumé

Certain subtypes of cancer cells require oxidative phosphorylation (OXPHOS) to survive. Increased OXPHOS dependency is frequently a hallmark of cancer stem cells and cells resistant to chemotherapy and targeted therapies. Suppressing the OXPHOS function might also influence the tumor microenvironment by alleviating hypoxia and improving the antitumor immune response. Thus, targeting OXPHOS is a promising strategy to treat various cancers. A growing arsenal of therapeutic agents is under development to inhibit this biological process. This Perspective provides an overview of the structure and function of OXPHOS complexes, their biological functions in cancer, relevant research tools and models, as well as the limitations of OXPHOS as drug targets. We also focus on the current development status of OXPHOS inhibitors and potential therapeutic strategies to strengthen their clinical applications.

Identifiants

pubmed: 33103432
doi: 10.1021/acs.jmedchem.0c01013
pmc: PMC9298160
mid: NIHMS1810330
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

14276-14307

Subventions

Organisme : NCI NIH HHS
ID : R01 CA188252
Pays : United States

Références

Cell Stem Cell. 2013 Mar 7;12(3):329-41
pubmed: 23333149
Nature. 2014 Oct 30;514(7524):628-32
pubmed: 25119024
Elife. 2018 Oct 02;7:
pubmed: 30277212
Clin Cancer Res. 2015 Mar 15;21(6):1360-72
pubmed: 25547679
Hepatology. 2014 Sep;60(3):1015-22
pubmed: 24799086
J Pharmacol Exp Ther. 2014 Nov;351(2):298-307
pubmed: 25125579
Nat Commun. 2020 Mar 6;11(1):1228
pubmed: 32144272
Science. 2015 Jan 2;347(6217):44-9
pubmed: 25554780
Neoplasia. 2005 Dec;7(12):1053-7
pubmed: 16354587
Int J Urol. 2006 May;13(5):587-92
pubmed: 16771730
Cancer Res. 2016 Jul 1;76(13):3904-15
pubmed: 27216187
Chem Biol. 2001 Jan;8(1):71-80
pubmed: 11182320
Nat Commun. 2014;5:3295
pubmed: 24548894
J Biol Chem. 2016 Jan 1;291(1):42-57
pubmed: 26521302
Trends Cancer. 2017 Nov;3(11):768-779
pubmed: 29120753
Nat Protoc. 2012 May 31;7(6):1235-46
pubmed: 22653162
Leukemia. 2013 Nov;27(11):2129-38
pubmed: 23568147
Cardiovasc Res. 2008 Jan 15;77(2):406-15
pubmed: 17900548
N Engl J Med. 2016 Sep 22;375(12):1109-12
pubmed: 27653561
Cancer Sci. 2018 Mar;109(3):699-709
pubmed: 29285837
Toxicol Lett. 2010 Sep 1;197(3):175-82
pubmed: 20576494
Invest New Drugs. 2019 Aug;37(4):684-692
pubmed: 30460505
Biotechniques. 2011 Feb;50(2):98-115
pubmed: 21486251
J Pharmacol Exp Ther. 2006 Jan;316(1):200-7
pubmed: 16174799
Cell Rep. 2020 Feb 11;30(6):1798-1810.e4
pubmed: 32049011
Clin Cancer Res. 2019 Nov 1;25(21):6429-6442
pubmed: 31439581
Nat Rev Endocrinol. 2014 Mar;10(3):143-56
pubmed: 24393785
Cancer Cell. 2013 Jun 10;23(6):811-25
pubmed: 23764003
EMBO J. 2013 Jan 9;32(1):9-29
pubmed: 23149385
Expert Opin Drug Metab Toxicol. 2014 Aug;10(8):1061-7
pubmed: 25023361
Nucleic Acids Res. 2004 Jan 1;32(Database issue):D258-61
pubmed: 14681407
Nature. 2014 Apr 3;508(7494):108-12
pubmed: 24670634
Aging (Albany NY). 2016 Aug;8(8):1593-607
pubmed: 27344270
Blood. 2016 Oct 6;128(14):1845-1853
pubmed: 27531676
Cell Cycle. 2011 Dec 1;10(23):4047-64
pubmed: 22134189
Nat Commun. 2019 May 17;10(1):2205
pubmed: 31101821
Biochem J. 2014 Sep 15;462(3):475-87
pubmed: 25017630
Toxicol Sci. 2015 Nov;148(1):241-60
pubmed: 26259608
Biochem Pharmacol. 1992 Apr 1;43(7):1545-53
pubmed: 1314606
J Immunother Cancer. 2019 Sep 11;7(1):246
pubmed: 31511064
Clin Cancer Res. 2018 Jun 1;24(11):2482-2490
pubmed: 29420223
Ann Pharmacother. 1993 Oct;27(10):1183-7
pubmed: 8251683
J Bioenerg Biomembr. 2018 Aug;50(4):263-270
pubmed: 29687367
J Clin Invest. 2016 Oct 3;126(10):3739-3757
pubmed: 27571409
Genome Res. 2018 Nov;28(11):1747-1756
pubmed: 30341162
Proc Natl Acad Sci U S A. 2018 Oct 16;115(42):10756-10761
pubmed: 30201710
Cancer Chemother Pharmacol. 2013 Feb;71(2):523-30
pubmed: 23228990
Oncotarget. 2016 Dec 27;7(52):86313-86325
pubmed: 27861144
PLoS Comput Biol. 2019 Mar 28;15(3):e1006658
pubmed: 30921324
J Natl Cancer Inst. 2003 Feb 19;95(4):291-302
pubmed: 12591985
Nat Biotechnol. 2010 Mar;28(3):249-55
pubmed: 20160716
J Mol Endocrinol. 2016 Apr;56(3):261-71
pubmed: 26759391
Radiat Oncol. 2014 Sep 19;9:207
pubmed: 25234922
Biomed Res Int. 2015;2015:690492
pubmed: 26425550
Cell Death Differ. 2018 Mar;25(3):542-572
pubmed: 29229998
Diabetologia. 2017 Sep;60(9):1577-1585
pubmed: 28776086
Nat Prod Rep. 2016 Oct 28;33(10):1146-65
pubmed: 27307039
Adv Cancer Res. 2018;138:71-98
pubmed: 29551130
Int J Cancer. 2016 May 1;138(9):2231-46
pubmed: 26595876
BMC Biol. 2014 May 27;12:34
pubmed: 24884669
Mol Cancer Ther. 2016 Dec;15(12):2875-2886
pubmed: 27765848
Cell Chem Biol. 2017 Sep 21;24(9):1161-1180
pubmed: 28938091
Cancer Res. 2003 Oct 15;63(20):6870-6
pubmed: 14583485
Nat Med. 2018 Jul;24(7):1047-1057
pubmed: 29892061
Org Lett. 2006 Feb 16;8(4):589-92
pubmed: 16468718
Cancer Discov. 2017 Jul;7(7):716-735
pubmed: 28416471
Oncotarget. 2016 Oct 4;7(40):65643-65659
pubmed: 27582539
J Clin Invest. 2002 Oct;110(8):1123-32
pubmed: 12393848
Cancer Cell. 2019 Jul 8;36(1):84-99.e8
pubmed: 31287994
Crit Care. 2005 Jun;9(3):R280-4
pubmed: 15987402
Nature. 2018 Feb 1;554(7690):128-132
pubmed: 29364879
Mitochondrion. 2017 Jul;35:13-22
pubmed: 28476317
Mol Pharmacol. 2011 May;79(5):814-22
pubmed: 21278232
Cell Metab. 2017 Oct 3;26(4):633-647.e7
pubmed: 28978427
Cancer Lett. 2017 Mar 1;388:149-157
pubmed: 27939695
Protein Cell. 2011 Jul;2(7):531-42
pubmed: 21822798
Clin Cancer Res. 2009 Mar 1;15(5):1593-600
pubmed: 19223492
Cell Rep. 2018 Apr 3;23(1):58-67
pubmed: 29617673
Neuro Oncol. 2017 Feb 1;19(2):197-207
pubmed: 27571886
Mol Cell. 2009 Jan 30;33(2):237-47
pubmed: 19187764
Cell. 2015 Jul 30;162(3):540-51
pubmed: 26232224
J Biol Chem. 1975 Jul 10;250(13):4992-5
pubmed: 125277
J Med Chem. 2010 Feb 25;53(4):1563-78
pubmed: 20092323
Ann Oncol. 2014 Dec;25(12):2295-2303
pubmed: 25344359
Chem Res Toxicol. 2018 Jun 18;31(6):494-505
pubmed: 29722540
J Biol Chem. 2007 Oct 5;282(40):29514-20
pubmed: 17681940
Proc Natl Acad Sci U S A. 2003 Jan 21;100(2):473-7
pubmed: 12515859
Theranostics. 2018 Jul 16;8(15):4050-4061
pubmed: 30128035
Int J Cancer. 2020 Jan 1;146(1):10-17
pubmed: 31396957
Biochim Biophys Acta. 2008 Jul-Aug;1777(7-8):882-9
pubmed: 18433712
Mol Cell Biol. 2015 Jan;35(1):182-98
pubmed: 25332241
Basic Res Cardiol. 2009 Mar;104(2):121-9
pubmed: 19242645
Cancer Discov. 2019 May;9(5):628-645
pubmed: 30787016
Nature. 2013 Feb 28;494(7438):443-8
pubmed: 23417064
Nat Cell Biol. 2017 Sep;19(9):1017-1026
pubmed: 28812580
Am J Physiol Heart Circ Physiol. 2015 Nov;309(9):H1453-67
pubmed: 26386112
J Biol Chem. 2019 Jan 11;294(2):679-696
pubmed: 30425100
Lupus. 2010 Nov;19(13):1492-501
pubmed: 20647250
J Pharmacol Exp Ther. 2008 Mar;324(3):938-47
pubmed: 18055879
Front Endocrinol (Lausanne). 2019 May 07;10:294
pubmed: 31133988
Cancer Metab. 2017 Aug 22;5:6
pubmed: 28852500
Int J Mol Sci. 2015 Jul 07;16(7):15287-308
pubmed: 26198225
Cancer Prev Res (Phila). 2013 Aug;6(8):801-10
pubmed: 23771523
J Pharmacol Exp Ther. 2004 Oct;311(1):109-14
pubmed: 15166256
J Biochem Mol Toxicol. 2018 Sep;32(9):e22195
pubmed: 30004155
J Biochem. 2009 Sep;146(3):383-7
pubmed: 19505951
Cell. 2005 Jul 1;121(7):1043-57
pubmed: 15989954
Cell Rep. 2014 Apr 10;7(1):27-34
pubmed: 24685140
J Biol Chem. 2016 Nov 11;291(46):24188-24199
pubmed: 27679486
Nat Genet. 2014 Jun;46(6):583-7
pubmed: 24816255
J Biol Chem. 1957 Feb;224(2):963-9
pubmed: 13405925
J Mol Cell Cardiol. 2009 Jun;46(6):804-10
pubmed: 19285082
Cancer Res. 2019 Aug 15;79(16):4072-4085
pubmed: 31227482
Cancer Lett. 2016 Jan 28;370(2):232-41
pubmed: 26522259
Front Endocrinol (Lausanne). 2018 Jul 09;9:338
pubmed: 30038596
J Cell Biochem. 2007 Sep 1;102(1):98-109
pubmed: 17372917
Cell. 2016 Dec 1;167(6):1598-1609.e10
pubmed: 27912063
Am J Cancer Res. 2015 Jan 15;5(2):689-701
pubmed: 25973307
Toxicol In Vitro. 2018 Oct;52:374-383
pubmed: 30030051
BMJ. 2005 Jun 4;330(7503):1304-5
pubmed: 15849206
Toxicol Appl Pharmacol. 2008 Dec 1;233(2):203-10
pubmed: 18817800
Toxicol Sci. 2007 Jun;97(2):539-47
pubmed: 17361016
Mol Cell. 2019 Sep 19;75(6):1131-1146.e6
pubmed: 31492636
Nat Med. 2017 Oct;23(10):1234-1240
pubmed: 28920959
Curr Med Chem. 2009;16(10):1266-77
pubmed: 19355884
Biochem Biophys Res Commun. 2012 Sep 14;426(1):94-9
pubmed: 22922102
Cancer Res. 1997 Aug 15;57(16):3424-8
pubmed: 9270008
Cell Rep. 2019 Jan 8;26(2):469-482.e5
pubmed: 30625329
Mol Cell. 2018 Feb 15;69(4):610-621.e5
pubmed: 29452640
Blood. 2015 Mar 26;125(13):2120-30
pubmed: 25631767
Cancer Cell. 2018 Aug 13;34(2):186-195
pubmed: 29805076
Diabetes Care. 2012 Mar;35(3):e21
pubmed: 22355024
J Pharmacol Exp Ther. 2015 May;353(2):392-404
pubmed: 25720766
Diabetes Care. 2006 Feb;29(2):254-8
pubmed: 16443869
Cancer Res. 2012 May 15;72(10):2634-44
pubmed: 22431711
Cell Syst. 2015 Dec 23;1(6):417-425
pubmed: 26771021
Nat Cell Biol. 2020 Mar;22(3):310-320
pubmed: 32144411
Proc Natl Acad Sci U S A. 2013 Nov 5;110(45):18226-31
pubmed: 24145418
Biochim Biophys Acta. 2013 Nov;1830(11):5175-83
pubmed: 23872355
Biochim Biophys Acta. 2006 Sep-Oct;1757(9-10):1073-83
pubmed: 16935256
Microbiol Mol Biol Rev. 2008 Dec;72(4):590-641, Table of Contents
pubmed: 19052322
Trends Endocrinol Metab. 2012 Sep;23(9):420-8
pubmed: 22819213
Cancer Cell. 2013 Mar 18;23(3):302-15
pubmed: 23477830
Biochem Med Metab Biol. 1992 Oct;48(2):122-6
pubmed: 1329873
Nature. 2019 Mar;567(7748):341-346
pubmed: 30842654
Chem Res Toxicol. 2019 Jan 22;32(1):156-167
pubmed: 30525499
Cell Metab. 2016 Apr 12;23(4):567-8
pubmed: 27076069
Clin Cancer Res. 2014 May 1;20(9):2249-56
pubmed: 24789032
Biochim Biophys Acta. 2010 Dec;1797(12):1877-82
pubmed: 20175986
Transplantation. 2001 Feb 15;71(3):352-9
pubmed: 11233893
Cancer Discov. 2012 Sep;2(9):778-90
pubmed: 22926251
Cancer Res. 2006 Nov 1;66(21):10269-73
pubmed: 17062558
Cancer Res. 1998 Jul 1;58(13):2720-3
pubmed: 9661880
Cell Metab. 2015 Oct 6;22(4):590-605
pubmed: 26365176
Neurosci Lett. 2001 Jun 8;305(2):91-4
pubmed: 11376891
Oncotarget. 2016 Jun 7;7(23):34084-99
pubmed: 27136895
Cytometry. 2002 Nov 1;49(3):106-12
pubmed: 12442310
Cancer Med. 2013 Oct;2(5):611-24
pubmed: 24403227
J Pharmacol Exp Ther. 2018 Oct;367(1):20-27
pubmed: 30002095
Exp Mol Med. 2018 Dec 6;50(12):1-15
pubmed: 30523246
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
Biochem Pharmacol. 1995 Nov 9;50(10):1599-606
pubmed: 7503762
Nat Rev Cancer. 2020 Sep;20(9):516-531
pubmed: 32632251
Biochem J. 2011 Apr 15;435(2):297-312
pubmed: 21726199
Proc Natl Acad Sci U S A. 1996 Jul 9;93(14):6913-7
pubmed: 8692918
Biochim Biophys Acta. 2008 Jul-Aug;1777(7-8):660-5
pubmed: 18486594
Oncotarget. 2017 Feb 14;8(7):11841-11854
pubmed: 28060746
J Mol Biol. 2004 Jul 30;341(1):281-302
pubmed: 15312779
Mol Cancer Ther. 2010 May;9(5):1092-9
pubmed: 20442309
Cytometry A. 2005 Feb;63(2):69-76
pubmed: 15655802
Hypoxia (Auckl). 2015 Dec 11;3:83-92
pubmed: 27774485
Evid Based Complement Alternat Med. 2013;2013:910451
pubmed: 23840269
J Biol Chem. 2003 Mar 7;278(10):8516-25
pubmed: 12496265
Biochim Biophys Acta. 2016 Dec;1866(2):151-162
pubmed: 27497601
J Biol Chem. 2005 Jul 22;280(29):27458-65
pubmed: 15917236
Nature. 2016 Sep 21;537(7622):639-43
pubmed: 27654917
JCI Insight. 2019 Feb 21;4(4):
pubmed: 30668548
Biopreserv Biobank. 2015 Oct;13(5):311-9
pubmed: 26484571
Elife. 2014 May 13;3:e02242
pubmed: 24843020
Cancer Prev Res (Phila). 2008 Dec;1(7):577-87
pubmed: 19139008
Genes Dev. 2012 Sep 1;26(17):1926-44
pubmed: 22899010
Pathology. 2016 Dec;48(7):675-683
pubmed: 27780605
Bioorg Med Chem Lett. 2008 Sep 1;18(17):4872-5
pubmed: 18691886
Front Pharmacol. 2019 Sep 18;10:1042
pubmed: 31619992
Exp Gerontol. 2005 Aug-Sep;40(8-9):685-93
pubmed: 16125352
Front Oncol. 2017 Jun 08;7:118
pubmed: 28642839
Int J Cell Biol. 2012;2012:273947
pubmed: 22675360
J Biol Chem. 2006 Mar 3;281(9):5965-72
pubmed: 16371358
J Endocrinol. 2016 Mar;228(3):R97-106
pubmed: 26743209
Cancer Metab. 2015 Oct 20;3:11
pubmed: 26500770
Biochem Biophys Res Commun. 2004 Jan 23;313(4):984-91
pubmed: 14706639
Chem Res Toxicol. 2020 Jul 20;33(7):1780-1790
pubmed: 32338883
Br J Cancer. 2016 Jun 14;114(12):1305-12
pubmed: 27219018
Haematologica. 2002 Jun;87(6):663-4
pubmed: 12031927
Nat Cell Biol. 2008 Dec;10(12):1477-83
pubmed: 19029908
J Cell Biol. 2007 Jun 18;177(6):1029-36
pubmed: 17562787
Eur J Cancer. 2001 Feb;37(3):364-8
pubmed: 11239758
Cancer Discov. 2020 Feb;10(2):288-305
pubmed: 31771969
Oncol Rep. 2019 Nov;42(5):1745-1754
pubmed: 31485674
Elife. 2016 Nov 10;5:
pubmed: 27830641
Nat Chem Biol. 2016 Oct;12(10):779-86
pubmed: 27479743
Oncogene. 2006 Aug 7;25(34):4633-46
pubmed: 16892078
Trends Immunol. 2016 Mar;37(3):208-220
pubmed: 26858199
Sci Rep. 2016 Dec 07;6:38343
pubmed: 27924826
J Forensic Sci. 1986 Oct;31(4):1492-8
pubmed: 3783116
Mol Cancer Ther. 2015 Jun;14(6):1504-16
pubmed: 25911689
Gen Pharmacol. 1998 May;30(5):639-45
pubmed: 9559312
Cell Rep. 2019 Apr 16;27(3):820-834.e9
pubmed: 30995479
Trends Biochem Sci. 2017 Apr;42(4):312-325
pubmed: 28185716
Cancer Res. 2014 Jun 15;74(12):3317-31
pubmed: 24755473
J Biol Chem. 2020 May 22;295(21):7481-7491
pubmed: 32295842
Front Oncol. 2013 Sep 17;3:240
pubmed: 24062990
Eur Urol. 2013 May;63(5):920-6
pubmed: 22981675
Eur J Hum Genet. 2011 Jul;19(7):769-75
pubmed: 21364701
IUBMB Life. 2016 May;68(5):388-93
pubmed: 27015848
J Biol Chem. 2010 Oct 8;285(41):31277-84
pubmed: 20675386
Antioxid Redox Signal. 2008 Feb;10(2):179-206
pubmed: 18020963
Clin Cancer Res. 2018 Feb 15;24(4):972-984
pubmed: 29246941
J Clin Med. 2019 Sep 02;8(9):
pubmed: 31480808
J Clin Invest. 2013 Sep;123(9):3693-700
pubmed: 23999444
Chem Biol. 2005 Apr;12(4):485-96
pubmed: 15850986
Nature. 2020 Sep;585(7824):288-292
pubmed: 32641834
J Inherit Metab Dis. 2015 Jul;38(4):629-40
pubmed: 25778941
Nutr Cancer. 2014;66(2):167-76
pubmed: 24364743
Cancer Cell. 2012 Oct 16;22(4):547-60
pubmed: 23079663
Dev Cell. 2014 Apr 28;29(2):217-32
pubmed: 24746669
Oncogene. 2008 Jul 17;27(31):4324-35
pubmed: 18372923
Science. 1997 Jul 4;277(5322):60-6
pubmed: 9204897
Cancer Res. 2009 Oct 1;69(19):7507-11
pubmed: 19752085
Nat Commun. 2016 Jul 25;7:12308
pubmed: 27453292
Nucleic Acids Res. 2000 Jan 1;28(1):27-30
pubmed: 10592173
Genes Dev. 2013 Dec 15;27(24):2615-27
pubmed: 24352419
Pharmacol Res. 2020 Feb;152:104609
pubmed: 31862477
Front Genet. 2019 May 15;10:438
pubmed: 31156701
Front Immunol. 2018 Feb 19;9:270
pubmed: 29520272
Exp Cell Res. 2014 Apr 15;323(1):131-143
pubmed: 24480576
Neurobiol Dis. 2009 May;34(2):279-90
pubmed: 19385059
Nat Med. 2018 Jul;24(7):1036-1046
pubmed: 29892070
Neoplasia. 2015 Aug;17(8):671-84
pubmed: 26408259
Cell. 2015 Jul 30;162(3):552-63
pubmed: 26232225
Essays Biochem. 2010;47:53-67
pubmed: 20533900
Cancer Cell. 2019 May 13;35(5):798-815.e5
pubmed: 31031016
Nature. 2016 Sep 29;537(7622):644-648
pubmed: 27654913
Science. 2010 Jul 23;329(5990):448-51
pubmed: 20595580
Nat Rev Endocrinol. 2019 Oct;15(10):569-589
pubmed: 31439934
Science. 2018 May 11;360(6389):
pubmed: 29650704
Elife. 2016 Feb 22;5:
pubmed: 26901439
Mod Pathol. 2019 Apr;32(4):568-575
pubmed: 30425335
Biochemistry. 2015 Mar 24;54(11):2011-21
pubmed: 25719498
J Clin Pathol. 2016 Jan;69(1):70-5
pubmed: 26251521
J Cell Mol Med. 2017 Sep;21(9):1859-1869
pubmed: 28244639
Nat Protoc. 2014 Feb;9(2):421-38
pubmed: 24457333
Nat Biotechnol. 2013 Jun;31(6):522-9
pubmed: 23604282
Sci Transl Med. 2019 May 8;11(491):
pubmed: 31068440
Sci Transl Med. 2011 Jan 26;3(67):67ra8
pubmed: 21270339
Br J Cancer. 1991 Sep;64(3):593-7
pubmed: 1911204
Cell Mol Immunol. 2018 Mar;15(3):203-205
pubmed: 29082922
Front Cell Dev Biol. 2018 Sep 25;6:122
pubmed: 30320109
Int J Cancer. 2011 Aug 15;129(4):820-31
pubmed: 21520032
Cancer Discov. 2018 Feb;8(2):174-183
pubmed: 29247016
Am J Physiol Cell Physiol. 2007 Jan;292(1):C137-47
pubmed: 16971498
Angew Chem Int Ed Engl. 2006 Jan 30;45(6):872-93
pubmed: 16404760
PLoS One. 2013 Oct 18;8(10):e76518
pubmed: 24204632
Cancer Cell. 2013 Mar 18;23(3):287-301
pubmed: 23416000
Cell. 2017 Sep 7;170(6):1247-1257.e12
pubmed: 28844695

Auteurs

Yibin Xu (Y)

Department of Medicinal Chemistry, College of Pharmacy, Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan 48109, United States.

Ding Xue (D)

Department of Medicinal Chemistry, College of Pharmacy, Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan 48109, United States.

Armand Bankhead (A)

Department of Computational Medicine and Bioinformatics, University of Michigan Medical School, Ann Arbor, Michigan 48109, United States.
Department of Biostatistics, University of Michigan, School of Public Health, Ann Arbor, Michigan 48109, United States.

Nouri Neamati (N)

Department of Medicinal Chemistry, College of Pharmacy, Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan 48109, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH